Existing investors including BNP Paribas and J.P. Morgan backed the growth round.
"Inefficiencies in the proxy voting system have led to both issuers and investors, the crucial end users in the process, being disenfranchised with their experience, and Proxymity was founded to radically improve the process for everyone in the ecosystem radically, ensuring access to real-time data, full transparency of voting status and activity and regulatory compliance."
The funding was backed by investors including Lyva Labs and the Northern Powerhouse Investment Fund II.
"This funding allows us to take critical steps in validating and refining our technology. With the support of our partners, we are working to bring a practical solution to healthcare challenges. The collaboration between Lancaster University and Morecambe Bay NHS Foundation Trust laid the foundation for this innovation."
The pre-seed round was led by SFC Capital to support platform development and operational expansion.
"Noxus is addressing a crucial challenge for large enterprises: implementing AI in production to achieve meaningful productivity gains without the usual complexity or risks. As organizations worldwide explore how to build their AI workforce and capitalize on this next wave of innovation, Noxus takes a unique approach. They’ve developed a horizontal platform designed to democratize AI adoption for legacy companies, empowering them to compete and thrive in a rapidly evolving landscape. We’re proud to back João, Jorge, and their team as they enable organizations to seamlessly integrate AI into their operations and unlock its transformative potential."
Battery Ventures led the Series A round to support platform development and US expansion.
"Support is no longer just about closing tickets – it’s about building long-term relationships. The migration to collaborative, real-time channels is changing the way businesses interact with customers. Plain is the platform designed for this new reality, helping companies deliver support that’s fast, effective, and aligned with their customers’ needs."
The funding was led by Mercia Ventures and the North East Venture Fund to help bring the non-invasive health sensor to market.
"A build-up of lactic acid causes muscles to seize up and athletes to suddenly ‘hit a wall’, but it’s hard for them to know when this will happen without measuring lactate levels. Fingerprick tests are uncomfortable, fiddly and not always accurate. Our device will overcome these problems and provide continuous monitoring, rather than a one-off measurement. This latest funding, together with our partnership with a major global chip manufacturer, will enable us to bring it to market."